Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

633 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Haplotype structures of EPHX1 and their effects on the metabolism of carbamazepine-10,11-epoxide in Japanese epileptic patients.
Nakajima Y, Saito Y, Shiseki K, Fukushima-Uesaka H, Hasegawa R, Ozawa S, Sugai K, Katoh M, Saitoh O, Ohnuma T, Kawai M, Ohtsuki T, Suzuki C, Minami N, Kimura H, Goto Y, Kamatani N, Kaniwa N, Sawada J. Nakajima Y, et al. Among authors: hasegawa r. Eur J Clin Pharmacol. 2005 Mar;61(1):25-34. doi: 10.1007/s00228-004-0878-1. Epub 2005 Feb 4. Eur J Clin Pharmacol. 2005. PMID: 15692831 Clinical Trial.
UGT1A1 haplotypes associated with reduced glucuronidation and increased serum bilirubin in irinotecan-administered Japanese patients with cancer.
Sai K, Saeki M, Saito Y, Ozawa S, Katori N, Jinno H, Hasegawa R, Kaniwa N, Sawada J, Komamura K, Ueno K, Kamakura S, Kitakaze M, Kitamura Y, Kamatani N, Minami H, Ohtsu A, Shirao K, Yoshida T, Saijo N. Sai K, et al. Among authors: hasegawa r. Clin Pharmacol Ther. 2004 Jun;75(6):501-15. doi: 10.1016/j.clpt.2004.01.010. Clin Pharmacol Ther. 2004. PMID: 15179405
Population pharmacokinetics of gemcitabine and its metabolite in Japanese cancer patients: impact of genetic polymorphisms.
Sugiyama E, Kaniwa N, Kim SR, Hasegawa R, Saito Y, Ueno H, Okusaka T, Ikeda M, Morizane C, Kondo S, Yamamoto N, Tamura T, Furuse J, Ishii H, Yoshida T, Saijo N, Sawada J. Sugiyama E, et al. Among authors: hasegawa r. Clin Pharmacokinet. 2010 Aug;49(8):549-58. doi: 10.2165/11532970-000000000-00000. Clin Pharmacokinet. 2010. PMID: 20608756
Haplotype analysis of ABCB1/MDR1 blocks in a Japanese population reveals genotype-dependent renal clearance of irinotecan.
Sai K, Kaniwa N, Itoda M, Saito Y, Hasegawa R, Komamura K, Ueno K, Kamakura S, Kitakaze M, Shirao K, Minami H, Ohtsu A, Yoshida T, Saijo N, Kitamura Y, Kamatani N, Ozawa S, Sawada J. Sai K, et al. Among authors: hasegawa r. Pharmacogenetics. 2003 Dec;13(12):741-57. doi: 10.1097/00008571-200312000-00005. Pharmacogenetics. 2003. PMID: 14646693
Genetic variations and haplotypes of CYP2C19 in a Japanese population.
Fukushima-Uesaka H, Saito Y, Maekawa K, Ozawa S, Hasegawa R, Kajio H, Kuzuya N, Yasuda K, Kawamoto M, Kamatani N, Suzuki K, Yanagawa T, Tohkin M, Sawada J. Fukushima-Uesaka H, et al. Among authors: hasegawa r. Drug Metab Pharmacokinet. 2005 Aug;20(4):300-7. doi: 10.2133/dmpk.20.300. Drug Metab Pharmacokinet. 2005. PMID: 16141610 Free article.
Four novel defective alleles and comprehensive haplotype analysis of CYP2C9 in Japanese.
Maekawa K, Fukushima-Uesaka H, Tohkin M, Hasegawa R, Kajio H, Kuzuya N, Yasuda K, Kawamoto M, Kamatani N, Suzuki K, Yanagawa T, Saito Y, Sawada J. Maekawa K, et al. Among authors: hasegawa r. Pharmacogenet Genomics. 2006 Jul;16(7):497-514. doi: 10.1097/01.fpc.0000215069.14095.c6. Pharmacogenet Genomics. 2006. PMID: 16788382
Genetic variations of the ABC transporter gene ABCC3 in a Japanese population.
Fukushima-Uesaka H, Saito Y, Maekawa K, Hasegawa R, Suzuki K, Yanagawa T, Kajio H, Kuzuya N, Noda M, Yasuda K, Tohkin M, Sawada J. Fukushima-Uesaka H, et al. Among authors: hasegawa r. Drug Metab Pharmacokinet. 2007 Apr;22(2):129-35. doi: 10.2133/dmpk.22.129. Drug Metab Pharmacokinet. 2007. PMID: 17495421 Free article.
633 results